Pharmafile Logo

counterfeit medicines

New CEO for Merck Serono

Belén Garijo replaces Stefan Oschmann, who moves into a wider group role

- PMLiVE

Bioclusters benefit from pharma shake-up

Sweeping job cuts at Europe’s largest drugmakers in recent years have spread gloom through the pharma sector, but the release of talent is helping to drive the development of bioclusters

- PMLiVE

Hikma pushes further into Africa with Ethiopian JV

Forms alliance with MIDROC to create HikmaCure

- PMLiVE

Merck KGaA appoints new chief information officer

Promotes the head of its strategy realisation office James Stewart

- PMLiVE

Amgen and Onyx agree $10.4bn takeover deal

Deal provides indication of the premium big biopharma will pay to replenish pipelines

- PMLiVE

AZ adds to pipeline again with Amplimmune buy

Pharma company pays $500m via its MedImmune subsidiary for the small US biotech

Biotech threatened by UK drug pricing changes, says BIA

It says VBP will undermine the attractiveness of the sector for investors

- PMLiVE

Currencies hit Merck Serono sales but firm says it is ‘on course’

Overall groups sales down to €2.84bn for second quarter of 2013

- PMLiVE

Pfizer expands Xeljanz manufacturing capability in Ireland

Invests $130m in manufacturing in Dublin and Cork

- PMLiVE

Saatchi & Saatchi create Spanish restless legs syndrome campaign

Online public awareness push is in collaboration with UCB

- PMLiVE

Spanish pharma recovery won’t begin until after 2014

Country's pharmaceutical market is yet to hit rock bottom

- PMLiVE

Fresenius sells biotech business

Germany company's biotechnology arm picked up by Neopharm owners

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links